bmi

WHO now recommends GLP-1 for weight loss. How does it work?

Shortage of ‘breakthrough’ weight loss drugs will slow fight against obesity, WHO warns

WHO backs wider use of weight-loss medicines, calling obesity a chronic disease

WHO backs use of GLP-1 therapies for obesity, warns access will remain limited

WHO issues global guideline on the use of GLP-1 medicines in treating obesity

WHO warning over shortage of obesity jabs

World Health Organization issues first-ever guidelines for use of GLP-1 weight loss medications

WHO recommends GLP-1 drugs for obesity

How Genes and Environment Shape BMI Differences

Gene-environment interplay explaining individual variation in BMI outcomes: a systematic review and meta-analysis of studies using polygenic indices